C07K 14/075
Adenoviridae
C07K14/075 (Adenoviridae) appears on 71 US grants and 110 published applications in this corpus.
Search patents in C07K- Granted patents
- 71
- Published applications
- 110
- Assignees
- 74
- Inventors
- 186
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 3 |
| 2014 | 3 | 2 |
| 2015 | 5 | 7 |
| 2016 | 6 | 7 |
| 2017 | 3 | 5 |
| 2018 | 2 | 18 |
| 2019 | 5 | 6 |
| 2020 | 4 | 11 |
| 2021 | 7 | 10 |
| 2022 | 8 | 12 |
| 2023 | 7 | 16 |
| 2024 | 4 | 5 |
| 2025 | 14 | 6 |
| 2026 | 3 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Prostate targeting adeno-associated virus serotype vectors26 May 2026US 12,636,382 B2University of Massachusetts
- Engineered viral capsid polypeptides and uses thereof5 May 2026US 12,617,821 B2President and Fellows of Harvard College
- Adeno-associated virus with engineered capsid17 Feb 2026US 12,552,838 B2Tenaya Therapeutics, Inc.
- Generating HPV antigen-specific T cells from a naïve T cell population25 Nov 2025US 12,478,670 B2Children's National Medical Center
- Methods for using dual glycan binding AAV vectors11 Nov 2025US 12,466,860 B2The University of North Carolina at Chapel Hill
- Adenoviral vector vaccine, and preparation method and use thereof10 Sep 2026US 2026/0265702 A1Cansino Biologics Inc.
- Packaging plasmids for aav production3 Sep 2026US 2026/0258449 A1Biogen MA Inc.
- Novel aav capsid-modified strain and use thereof20 Nov 2025US 2025/0354168 A1Shanghai Langsheng Biotechnology Co., Ltd
- Targeted protein degradation system and use thereof6 Nov 2025US 2025/0340599 A1St Phi Therapeutics Co., Ltd.
- Recombinant adenoviruses and uses thereof30 Oct 2025US 2025/0333454 A1Beth Israel Deaconess Medical Center, Inc.
Most cited
By later US patents
- Methods for treatment of cancer368US 8,906,682 B2The Trustees of the University of Pennsylvania · 2014
- Compositions for treatment of cancer277US 8,911,993 B2The Trustees of the University of Pennsylvania · 2014
- Methods for treatment of cancer216US 8,916,381 B1The Trustees of the University of Pennyslvania · 2014
- Compositions for treatment of cancer199US 8,975,071 B1The Trustees of the University of Pennsylvania · 2015
- Methods for treatment of cancer199US 9,101,584 B2The Trustees of the University of Pennsylvania · 2015